With so many GLP-1 options now available, the real value lies in understanding which treatment and which dosing options align best with your individual goals
Meissner WG, Remy P, Giordana C, Maltete D, Derkinderen P, Houeto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carriere N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O, Group LS (2024) Trial of Lixisenatide in early Parkinsons disease
Constipation, while less common than diarrhea, may also occur and can be particularly problematic in patients with pre-existing constipation issues
Personal Opinion: The energy improvements I have observed in menopausal women using Retatrutide often exceed what weight loss alone would explain
Surprisingly, Valenta et al
They may be triggered by gastrointestinal issues, neurological diseases, autoimmune conditions, or even certain foods and medications